The gradual dose escalation protocol specifically addresses this issue by allowing your body to adapt before increasing the dose
Phase II, Dose-Ranging Trial A phase II, randomized, dose-finding trial of oral semaglutide was published in late 2017
Also, it can take years to complete studies that show additional benefits in other organs like the heart, kidneys, liver, etc
Link between insulin resistance and obesity-from diagnosis to treatment
[PMID: 40160348] PubMed record related to this compound for laboratory literature review
These medications were originally developed to help manage type 2 diabetes, but they also support weight loss by slowing stomach emptying, stabilizing blood sugar levels, and increasing feelings of fullness and satisfaction, which can reduce appetite